Massimo Coen
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 3
- HIV/AIDS drug development and treatment 2
-
- Antibiotic Resistance in Bacteria 3
- Co-authors
- Giuseppe Landonio (2 shared papers)Paola Maria Cinque (2 shared papers)Adriano Lazzarin (2 shared papers)Liliana Caggese (1 shared paper)Umberto Tirelli (1 shared paper)Francesco Rizzo (1 shared paper)Annamaria Nosari (1 shared paper)Umberto di Luzio Paparatti (1 shared paper)
In The Last Decade
Massimo Coen
15 papers receiving 874 citations
Peers
Comparison fields: 5 of 66
- Infectious Diseases 502
- Molecular Medicine 177
- Applied Microbiology and Biotechnology 26
- Critical Care and Intensive Care Medicine 24
- Pharmacology 64
Countries citing papers authored by Massimo Coen
This map shows the geographic impact of Massimo Coen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Coen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Coen more than expected).
Fields of papers citing papers by Massimo Coen
This network shows the impact of papers produced by Massimo Coen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Coen. The network helps show where Massimo Coen may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Coen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 206 | |
| 2 | 2021 | 202 | |
| 3 | 2020 | 160 | |
| 4 | 2018 | 144 | |
| 5 | 2020 | 60 | |
| 6 | 2020 | 35 | |
| 7 | 1993 | 24 | |
| 8 | 1993 | 11 | |
| 9 | 2014 | 10 | |
| 10 | 2018 | 9 | |
| 11 | 2023 | 9 | |
| 12 | 2015 | 8 | |
| 13 | 2015 | 6 | |
| 14 | 2006 | 5 | |
| 15 | 2024 | 1 | |
| 16 | 2016 | 0 |
About Massimo Coen
Massimo Coen is a scholar working on Infectious Diseases, Molecular Medicine, Virology, Hematology and Surgery, having authored 16 papers that have together received 890 indexed citations. Recurring topics across this work include Orthopedic Infections and Treatments (4 papers), COVID-19 Clinical Research Studies (3 papers), Antibiotic Resistance in Bacteria (3 papers), HIV Research and Treatment (2 papers), Platelet Disorders and Treatments (2 papers), HIV/AIDS drug development and treatment (2 papers), Vector-borne infectious diseases (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Infectious Diseases (502 citations), Molecular Medicine (177 citations), Applied Microbiology and Biotechnology (26 citations), Critical Care and Intensive Care Medicine (24 citations) and Pharmacology (64 citations). Massimo Coen has collaborated with scholars based in Italy and France. Frequent co-authors include Giuseppe Landonio, Paola Maria Cinque, Adriano Lazzarin, Liliana Caggese, Umberto Tirelli, Francesco Rizzo, Annamaria Nosari, Umberto di Luzio Paparatti, Sebastiano Recalcati and Lucia Restano. Their work appears in journals such as Antibiotics, AIDS, Pharmacological Research, International Journal of Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.